News


Keapstone Therapeutics and Sygnature Discovery collaborate to discover new therapies for Parkinson’s and Motor Neuron Disease

Keapstone Therapeutics, a new biotech company formed by the University of Sheffield and Parkinson’s UK to develop new drugs for Parkinson’s and other neurodegenerative diseases, and Sygnature Discovery, the UK’s largest independent provider of integrated drug discovery resource and expertise, today announced they will collaborate to discover new treatments for Parkinson’s and Motor Neuron Disease […]

Sygnature Discovery, Mironid®, and Peak Proteins to collaborate to discover new therapies for life-threatening and currently incurable kidney disease, ADPKD

Sygnature Discovery, Mironid® Limited, a leader in cell signalling-directed drug discovery and Peak Proteins, have announced they will work closely together to discover new therapies against diseases driven by elevated cyclic AMP (cAMP), such as Autosomal Dominant Polycystic Kidney Disease (ADPKD). ADPKD is a devastating, life-threatening and currently incurable genetic disorder in which kidney cysts […]


View All News
Conferences

Meet Sygnature at the following Conferences throughout 2015:



Biotech Showcase/JP Morgan

9-11th January 2017
San Francisco USA


RSC OrgSyn 50

27-28 February 2017
Manchester UK


Proventa Medicinal Chemistry Strategy

14th March 2017
London



View All Conferences
Media

Sygnature Discovery



View All Media
Publications

KINASE INHIBITORS, FRICKEL, Fritz-Frieder

KINASE INHIBITORS, FRICKEL, Fritz-Frieder; FYFE, Matthew, Colin, Thor; MEGHANI, Premji; THOM, Stephen, Malcolm; (RespiVert Ltd. and TopiVert Ltd.), WO 2014076484 (2014).


PYRAZOLE DERIVATIVES AS P38 MAP INHIBITORS, DUFFY, Lorna Anne

PYRAZOLE DERIVATIVES AS P38 MAP INHIBITORS, DUFFY, Lorna Anne; KING-UNDERWOOD, John; LONGSHAW, Alistair Ian; MURRAY, Peter John; ONIONS, Stuart Thomas; TADDEI, David Michael Adrien; WILLIAMS, Jonathan Gareth; ITO, Kazuhiro; CHARRON, Catherine Elisabeth; (GB) (RespiVert Ltd. and TopiVert Ltd.), WO 2014033448 (2014).


KINASE INHIBITORS, FYFE, Matthew Colin Thor

KINASE INHIBITORS, FYFE, Matthew Colin Thor; MEGHANI, Premji; STENT, Matthew Alexander Henry; THOM, Stephen Malcolm; WALSHE, Claire Anne; (RespiVert Ltd. and TopiVert Ltd.), WO 2014033447 (2014).



View All Publications
Copyright © 2017 Sygnature Discovery

Website built by AtomicMedia - Design by Freestyle.